Phenominer

	Submit Data \| Help \| Video Tutorials \| News \| Publications \| Download \| REST API \| Citing RGD \| Contact
	Search RGD Grant Resources Citing RGD About Us Contact Us Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease Find Models new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive Pathways Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
	Advanced Search (OLGA)

PhenoMiner Database Result

View data table

Download data table

View expanded data table

Generate Chart For

(Chart displayed below)

Rat Strains

Measurement Methods

Age

Experimental Conditions

Minimum Value:

Maximum Value:

Sex:

Options:

View chart

Download data table

View expanded data table

# of Animals	Phenotype	Strain	Sex	Value	Units	Conditions	Record ID	Condition 1	Condition 2	Condition 3	Condition 4
10	plasma insulin level	F344/NHsd	female	17	mU/l	fasting (for 16 hours) then glucose solution (2 g/kg)	11615	fasting (for 16 hours)	glucose solution (2 g/kg)
10	plasma insulin level	WKY/NHsd	female	20	mU/l	fasting (for 16 hours) then glucose solution (2 g/kg)	11614	fasting (for 16 hours)	glucose solution (2 g/kg)
10	plasma insulin level	F344/NHsd	male	43	mU/l	fasting (for 16 hours) then glucose solution (2 g/kg)	11613	fasting (for 16 hours)	glucose solution (2 g/kg)
10	plasma insulin level	WKY/NHsd	male	64.1	mU/l	fasting (for 16 hours) then glucose solution (2 g/kg)	11612	fasting (for 16 hours)	glucose solution (2 g/kg)
N/A	plasma insulin level	Crl:SD	male	53	mU/l	controlled fructose content diet (66 %) (between 14 and 28 days)	75879	controlled fructose content diet (66 %) (between 14 and 28 days)
8	plasma insulin level	Crl:SD	male	68	mU/l	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days)	75880	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days)	controlled fructose content diet (66 %) (between 14 and 28 days)	insulin (2 U/kg/d) (for 14 days)
9	plasma insulin level	Crl:SD	male	51	mU/l	controlled fructose content diet (66 %) (between 14 and 28 days)	75847	controlled fructose content diet (66 %) (between 14 and 28 days)
8	plasma insulin level	Crl:SD	male	33	mU/l	control condition	75848	control condition
10	plasma insulin level	Crl:SD	male	32	mU/l	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days)	75849	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days)	controlled fructose content diet (66 %) (between 14 and 28 days)
8	plasma insulin level	Crl:SD	male	26	mU/l	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days)	75850	controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days)
4	plasma insulin level	Crl:WI	male	14.5	mU/l	control condition	103089	control condition
4	plasma insulin level	GK/CskCrljCrl	male	12.32	mU/l	control condition	103090	control condition
12	plasma insulin level	SS	male	4	mU/l	controlled sodium content diet (0.3 %) (for 42 days)	103326	controlled sodium content diet (0.3 %) (for 42 days)
13	plasma insulin level	SR	male	4	mU/l	controlled sodium content diet (0.3 %) (for 42 days)	103327	controlled sodium content diet (0.3 %) (for 42 days)
13	plasma insulin level	SS	male	5	mU/l	controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days)	103328	controlled sodium content diet (0.3 %) (for 42 days)	controlled sodium content diet (8 %) (for 42 days)
11	plasma insulin level	SR	male	5	mU/l	controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days)	103329	controlled sodium content diet (0.3 %) (for 42 days)	controlled sodium content diet (8 %) (for 42 days)
12	plasma insulin level	SS	male	6	mU/l	controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days)	103330	controlled sodium content diet (0.3 %) (for 42 days)	controlled sodium content diet (8 %) (for 84 days)
13	plasma insulin level	SR	male	5	mU/l	controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days)	103331	controlled sodium content diet (0.3 %) (for 42 days)	controlled sodium content diet (8 %) (for 84 days)
6	plasma insulin level	GK	male	101	mU/l	controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days)	110616	controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days)
6	plasma insulin level	GK	female	42	mU/l	controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days)	110618	controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days)
10	plasma insulin level	BN/NHsdMcwi	male	20.37	mU/l	controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)	102092	controlled sodium chloride content drinking water (1 %) (for 7 days)	controlled sodium chloride content drinking water (2 %) (for 7 days)	controlled sodium chloride content drinking water (1 %) (for 9 days)	water (for 12 days)
10	plasma insulin level	LH/Mav	male	29.17	mU/l	controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)	102093	controlled sodium chloride content drinking water (1 %) (for 7 days)	controlled sodium chloride content drinking water (2 %) (for 7 days)	controlled sodium chloride content drinking water (1 %) (for 9 days)	water (for 12 days)
10	plasma insulin level	LH-Chr 13BN/Mav	male	30.84	mU/l	controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)	102094	controlled sodium chloride content drinking water (1 %) (for 7 days)	controlled sodium chloride content drinking water (2 %) (for 7 days)	controlled sodium chloride content drinking water (1 %) (for 9 days)	water (for 12 days)
9	plasma insulin level	BN-Chr 13LH/MavRrrc	male	23.41	mU/l	controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)	102095	controlled sodium chloride content drinking water (1 %) (for 7 days)	controlled sodium chloride content drinking water (2 %) (for 7 days)	controlled sodium chloride content drinking water (1 %) (for 9 days)	water (for 12 days)
10	plasma insulin level	HTG	not specified	13	mU/l	fasting (for 16 hours)	68984	fasting (for 16 hours)
10	plasma insulin level	BN/OrlIcoCrlf	not specified	14.04	mU/l	fasting (for 16 hours)	68985	fasting (for 16 hours)
10	plasma insulin level	COP/OlaHsd	not specified	29.12	mU/l	fasting (for 16 hours)	68572	fasting (for 16 hours)
10	plasma insulin level	COP.DA-(D16Rat12-D16Rat90)/Mco	not specified	32.5	mU/l	fasting (for 16 hours)	68573	fasting (for 16 hours)
10	plasma insulin level	COP.DA-(D3Rat233-D3Mgh14)/Mco	not specified	26.52	mU/l	fasting (for 16 hours)	68574	fasting (for 16 hours)
6	plasma insulin level	GK/MolTac	male	37.18	mU/l	fasting (for 12 hours)	103811	fasting (for 12 hours)
4	plasma insulin level	GK/MolTac	male	38.74	mU/l	sodium chloride solution (for 23 days) then fasting (for 12 hours)	103812	sodium chloride solution (for 23 days)	fasting (for 12 hours)
3	plasma insulin level	GK/MolTac	male	30.42	mU/l	rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours)	103813	rosiglitazone (5 mg/kg) (for 23 days)	fasting (for 12 hours)
4	plasma insulin level	GK/MolTac	male	34.58	mU/l	rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours)	103814	rosiglitazone (10 mg/kg) (for 23 days)	fasting (for 12 hours)
4	plasma insulin level	GK/MolTac	male	37.96	mU/l	sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours)	103815	sodium chloride solution (for 23 days)	control condition (for 20 days)	fasting (for 12 hours)
4	plasma insulin level	GK/MolTac	male	38.22	mU/l	rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours)	103816	rosiglitazone (5 mg/kg) (for 23 days)	control condition (for 20 days)	fasting (for 12 hours)
4	plasma insulin level	GK/MolTac	male	27.3	mU/l	rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours)	103817	rosiglitazone (10 mg/kg) (for 23 days)	control condition (for 20 days)	fasting (for 12 hours)
6	plasma insulin level	Crl:WI(Han)	female	221	mU/l	sham surgical control condition (for 24 days)	103761	sham surgical control condition (for 24 days)
6	plasma insulin level	Crl:WI(Han)	female	213.2	mU/l	bilateral ovariectomy (for 24 days)	103762	bilateral ovariectomy (for 24 days)
6	plasma insulin level	GK	female	26	mU/l	sham surgical control condition (for 24 days)	103763	sham surgical control condition (for 24 days)
6	plasma insulin level	GK	female	23.4	mU/l	bilateral ovariectomy (for 24 days)	103764	bilateral ovariectomy (for 24 days)
6	plasma insulin level	SD-Lepem1Sage-/-	female	971.88	mU/l	fasting (for 4 hours)	104457	fasting (for 4 hours)
6	plasma insulin level	SD-Lepem1Sage+/+	male	14.82	mU/l	fasting (for 4 hours)	104454	fasting (for 4 hours)
6	plasma insulin level	SD-Lepem1Sage-/-	male	327.08	mU/l	fasting (for 4 hours)	104455	fasting (for 4 hours)
6	plasma insulin level	SD-Lepem1Sage+/+	female	18.2	mU/l	fasting (for 4 hours)	104456	fasting (for 4 hours)
10	plasma insulin level	GK	male	11.96	mU/l	fasting (for 16 hours)	109082	fasting (for 16 hours)
10	plasma insulin level	GK	male	11.44	mU/l	fasting (for 16 hours)	109083	fasting (for 16 hours)
10	plasma insulin level	GK	male	11.7	mU/l	fasting (for 16 hours)	109085	fasting (for 16 hours)
5	plasma insulin level	Crlj:WI	male	62.4	mU/l	fasting (for 17 hours)	108088	fasting (for 17 hours)
44	plasma insulin level	Slc:ZUC-Leprfa-/-	male	384.8	mU/l	fasting (for 17 hours)	106938	fasting (for 17 hours)
10	plasma insulin level	GK/CskCrlj	male	28.6	mU/l	fasting (for 17 hours)	106892	fasting (for 17 hours)
8	plasma insulin level	Crl:WI	male	6.24	mU/l	control condition	105532	control condition
8	plasma insulin level	WI-Mc4rm1Hubr	male	39	mU/l	control condition	105533	control condition
9	plasma insulin level	Slc:ZUC-Leprfa+	male	26	mU/l	fasting (for 17 hours)	108658	fasting (for 17 hours)
6	plasma insulin level	BN/Crl	male	6.396	mU/l	fasting (between 16 and 18 hours)	68776	fasting (between 16 and 18 hours)
6	plasma insulin level	BN/Crl	female	6.058	mU/l	fasting (between 16 and 18 hours)	68777	fasting (between 16 and 18 hours)
6	plasma insulin level	GK/Ox	male	18.798	mU/l	fasting (between 16 and 18 hours)	68778	fasting (between 16 and 18 hours)
6	plasma insulin level	GK/Ox	female	9.1	mU/l	fasting (between 16 and 18 hours)	68779	fasting (between 16 and 18 hours)
15	plasma insulin level	BN/Crl	male	7.19425	mU/l	control condition	67327	control condition
12	plasma insulin level	BN.GK-(D8Rat29-D8Got130)/Ox	male	4.02878	mU/l	control condition	67328	control condition
15	plasma insulin level	BN.GK-(D8Got302-D8Got130)/Ox	male	3.45324	mU/l	control condition	67329	control condition
20	plasma insulin level	BN/Crl	male	5.46763	mU/l	control condition	67330	control condition
12	plasma insulin level	BN.GK-(D8Rat29-D8Got130)/Ox	male	6.762595	mU/l	control condition	67331	control condition
11	plasma insulin level	BN.GK-(D8Got302-D8Got130)/Ox	male	3.309355	mU/l	control condition	67332	control condition
12	plasma insulin level	BN/Crl	female	4.31655	mU/l	control condition	67333	control condition
10	plasma insulin level	BN.GK-(D8Rat29-D8Got130)/Ox	female	6.04317	mU/l	control condition	67334	control condition
18	plasma insulin level	BN.GK-(D8Got302-D8Got130)/Ox	female	2.733815	mU/l	control condition	67335	control condition
10	plasma insulin level	BN/Crl	female	7.050365	mU/l	control condition	67336	control condition
7	plasma insulin level	BN.GK-(D8Rat29-D8Got130)/Ox	female	4.31655	mU/l	control condition	67337	control condition
10	plasma insulin level	BN.GK-(D8Got302-D8Got130)/Ox	male	5.323745	mU/l	control condition	67338	control condition

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.
NHLBI Logo

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Create Name:

Description:

Send us a Message